A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Burgess, MD, PhD
Celgene
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitari Germans Trias I Pujol Can Ruti
Badalona (Barcelona), Spain
- Duran I Reynals Institut Catala D'Oncologia
Barcelona, Spain
- Hospital Val D'Hebron
Barcelona, Spain
- Hospital 12 de Octubre
Madrid, Spain
- Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain
- Hospital Universitario de Salamanca
Salamanca, Spain
- Hospital Marques de Valdecilla
Santander, Spain
- Hospital de la Fe
Valencia, Spain
- Scottsdale Healthcare Research Institute
Scottsdale, Arizona, United States
- University of Arizona Cancer Center
Tucson, Arizona, United States
- University of California San Francisco
San Francisco, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- South Texas Accelerated Research Therapeutics
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Mar 2015
- Primary completion
- 24 Dec 2020
- Completion
- 24 Dec 2020
- Last update posted
- 12 Aug 2021
- Registered enrollment
- 60
- Registry id
- NCT02367196
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.